Home/Filings/4/0001127602-23-007922
4//SEC Filing

Crum Brian T 4

Accession 0001127602-23-007922

CIK 0001062822other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:49 PM ET

Size

15.5 KB

Accession

0001127602-23-007922

Insider Transaction Report

Form 4
Period: 2023-02-28
Crum Brian T
SVP, General Counsel & Secr.
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2821,0300 total
    Common Stock (21,030 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-288,7508,750 total
    Common Stock (8,750 underlying)
  • Exercise/Conversion

    Common Stock

    2023-02-28+21,030120,488 total
  • Exercise/Conversion

    Common Stock

    2023-02-28+26,097155,335 total
  • Exercise/Conversion

    Common Stock

    2023-02-28+8,750129,238 total
  • Tax Payment

    Common Stock

    2023-02-28$2.17/sh20,537$44,565134,798 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2826,09752,193 total
    Common Stock (26,097 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001792747

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:49 PM ET
Size
15.5 KB